Cargando…
SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis
Emerging evidences demonstrate that metabolic reprogramming is a hallmark of malignancies, including gastric cancer (GC). Abnormal expression of metabolic rate-limiting enzymes, as the executive medium of energy metabolism, drives the occurrence and development of cancer. However, a comprehensive mo...
Autores principales: | Zhu, Tingting, Wang, Zhangding, Zou, Tianhui, Xu, Lei, Zhang, Shu, Chen, Yali, Chen, Chen, Zhang, Weijie, Wang, Shouyu, Ding, Qingqing, Xu, Guifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591064/ https://www.ncbi.nlm.nih.gov/pubmed/34790132 http://dx.doi.org/10.3389/fphar.2021.769647 |
Ejemplares similares
-
Risk Factors of Lymph Node Metastasis in Patients with Early Pure and Mixed Signet Ring Cell Gastric Carcinomas
por: Hu, Qingqing, et al.
Publicado: (2019) -
Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma
por: Wang, Zhangding, et al.
Publicado: (2021) -
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer
por: Chen, Shuoling, et al.
Publicado: (2020) -
Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis
por: Hu, Junqing, et al.
Publicado: (2019) -
Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner
por: Shi, Jiajun, et al.
Publicado: (2023)